Search
Adaptive Biotechnologies Corp
ADPTAdd to Watchlist
22.570USD
-1.610-6.66%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.59BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Adaptive Biotechnologies Corp is 8.50, ranking 108 out of 385 in the Biotechnology & Medical Research industry. The average price target is 20.00, with a high of 21.00 and a low of 18.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
23.333
Target Price
+3.43%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Adaptive Biotechnologies Corp
ADPT
8
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Adaptive Biotechnologies Corp's expected revenue for the next quarter?
Adaptive Biotechnologies Corp's expected revenue is 71.19M.
What is Adaptive Biotechnologies Corp's price target?
Analysts forecast that Adaptive Biotechnologies Corp's price target is USD 20.00, with the highest forecast at USD 21.00 and the lowest forecast at USD 18.00.
How have Adaptive Biotechnologies CorpADPT's recent earnings per share performed?
The market expectation was USD -0.25, while Adaptive Biotechnologies CorpADPT's earnings per share (EPS) for the previous quarter was USD -0.13. EPS for the next quarter is expected at USD -0.10.
What is the analyst rating for Adaptive Biotechnologies Corp?
Based on the ratings of Adaptive Biotechnologies Corp's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.